Futura Medical plc (AIM:FUM)

Market Cap	40.79M
Revenue (ttm)	13.93M
Net Income (ttm)	1.29M
Shares Out	303.83M
EPS (ttm)	0.00
PE Ratio	32.74
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	445,924
Average Volume	1,316,397
Open	13.71
Previous Close	13.43
Day's Range	13.05 - 14.45
52-Week Range	7.00 - 45.56
Beta	0.82
RSI	73.88
Earnings Date	Sep 11, 2025

About Futura Medical

Futura Medical plc research, develops, and sells pharmaceutical and healthcare products for sexual health. Its lead product is Eroxon, a topical gel for the treatment of erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2001
• Employees: 14
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: FUM